In this study, we found that CD117+CD44+CSC vaccine significantly suppressed the secretion of TGF-β in ovarian cancer tissues, which may be one of anti-ovarian cancer mechanisms by inhibition of ovarian carcinogenesis and regulating CSC properties. The gene discussed is CD44; the disease is ovarian carcinoma.